ETFs positioned on Iqvia Holdings Inc.

Name Weight AuM 1st Jan change Investor Rating
3.67% 0 M€ 0.00% -
3.45% 0 M€ 0.00% -
2.92% 1 M€ -.--% -
2.68% 2 M€ -.--%
1.54% 20 M€ +15.66% -
1.33% 1 M€ +2.21% -
1.20% 2 M€ -.--%
1.04% 7 M€ +13.24%
0.50% 9 M€ -.--% -
0.41% 2 M€ +20.44%
0.36% 5 M€ -72.95% -
0.24% 1,448 M€ -.--% -
0.21% 330 M€ -.--% -
0.19% 43 M€ -.--%
0.16% 11 M€ +21.23%
0.15% 10 M€ +22.60% -
0.15% 699 M€ +30.84%
0.15% 1 M€ +0.04%
0.14% 276 M€ +11.40% -
0.12% 135 M€ +27.66%
0.12% 6 M€ +17.98% -
0.12% 32,814 M€ +22.24% -
0.12% 167 M€ +16.76% -
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Employees
88,000
Calendar
10/12/2024 - Investor Day
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart IQVIA-HOLDINGS-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
200.84USD
Average target price
252.18USD
Spread / Average Target
+25.56%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IQV Stock
  4. ETFs Iqvia Holdings Inc.
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW